ModelEdge

Moonlake Immunotherapeutics
MLTX
Filing Type8-K
Filing Date2/22/2026
Updated2/23/26, 4:04 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Financial Results, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Changes in Board, Management or Compensation, Reg. FD, Other Events
EX-99.1Material Contracts, Financial Results, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Changes in Board, Management or Compensation, Reg. FD, Other Events